Last reviewed · How we verify

SPARC1104 modified dose regimen II — Competitive Intelligence Brief

SPARC1104 modified dose regimen II (SPARC1104 modified dose regimen II) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline.

phase 3 Small molecule Live · refreshed every 30 min

Target snapshot

SPARC1104 modified dose regimen II (SPARC1104 modified dose regimen II) — Sun Pharma Advanced Research Company Limited. SPARC1104 is a modified dose regimen of an undisclosed drug, but it is likely a small molecule targeting a specific molecular pathway.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
SPARC1104 modified dose regimen II TARGET SPARC1104 modified dose regimen II Sun Pharma Advanced Research Company Limited phase 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). SPARC1104 modified dose regimen II — Competitive Intelligence Brief. https://druglandscape.com/ci/sparc1104-modified-dose-regimen-ii. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: